Conference on the Use of BCG in Therapy of Cancer

LDR 01311nam a22003491 4500
001 001688095
003 MiAaHDL
005 20221205000000.0
006 m d
007 cr bn ---auaua
008 891207s1974 mdua f10000 eng d
010 ‡a74601741 //r864
035 ‡a(MiU)990016880950106381
035 ‡asdr-miu.990016880950106381
035 ‡asdr-umn9931538640001701
035 ‡asdr-uiuc711628
035 ‡asdr-nrlf.b171806360
035 ‡z(MiU)MIU01000000000000001688095-goog
035 ‡a(OCoLC)1104877
035 ‡a(SAZTEC)198208120
035 ‡a(CaOTULAS)176626513
035 ‡z(MiU)Aleph001688095
040 ‡aDLC ‡cDLC ‡dMiU
050 0 0 ‡aRC261 ‡b.A448 no. 39 ‡aRC271.B2
082 ‡a368.4/00973 s ‡a616.9/94/079
086 ‡aHE 20.3162:39
111 2 ‡aConference on the Use of BCG in Therapy of Cancer, ‡cNational Institutes of Health, ‡d1972.
245 0 0 ‡aConference on the Use of BCG in Therapy of Cancer.
260 ‡aBethesda, Md., ‡bNational Cancer Institute, ‡c1973 [i.e. 1974]
300 ‡ax, 276 p. ‡billus. ‡c27 cm.
490 0 ‡aDHEW publication no. (NIH) 74-511
490 0 ‡aNational Cancer Institute monograph ; ‡v39
538 ‡aMode of access: Internet.
650 0 ‡aCancer ‡xChemotherapy ‡xCongresses.
650 0 ‡aBCG vaccines ‡xCongresses.
710 2 ‡aNational Cancer Institute (U.S.)
899 ‡a39015004381946
CID ‡a001688095
DAT 0 ‡a19980109000000.0 ‡b20221205000000.0
DAT 1 ‡a20221207060734.0 ‡b2023-08-05T17:39:06Z
CAT ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-008
FMT ‡aBK
HOL ‡0sdr-miu.990016880950106381 ‡aMiU ‡bSDR ‡cMIU ‡f001688095 ‡pmdp.39015004381946 ‡sMIU ‡1990016880950106381
974 ‡bMIU ‡cMIU ‡d20230805 ‡sgoogle ‡umdp.39015004381946 ‡y1974 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bUMN ‡cUMN ‡d20240312 ‡sgoogle ‡uumn.31951000072082x ‡y1974 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bUIU ‡cUIUC ‡d20240409 ‡sgoogle ‡uuiug.30112005898769 ‡zv.39(1973) ‡y1974 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bUC ‡cNRLF ‡d20240919 ‡sgoogle ‡uuc1.b4513992 ‡y1974 ‡rpd ‡qbib ‡tUS fed doc